Nikhil Prasad Fact checked by:Thailand Medical News Team Jan 16, 2025 7 hours, 51 minutes ago
Medical News: Glioblastoma Multiforme (GBM), the most aggressive type of malignant brain tumor, is becoming an increasingly significant health issue across the United States. With a median survival rate of just 15 months and a five-year survival rate of only 7.2%, GBM is considered one of the most lethal forms of brain cancer. Recent research conducted by doctors from Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, and Hackensack University Medical Center in the United States, reveals a concerning upward trend in GBM cases.
Doctors Warn of Rising Cases of Glioblastoma Multiforme in the United States
The Study and Its Scope
This
Medical News report focuses on a comprehensive epidemiological investigation analyzing 100,000 GBM cases reported in the United States between 2000 and 2017. Using data from the SEER (Surveillance, Epidemiology, and End Results) program, researchers examined age-adjusted annual incidence rates and compared these findings to those of non-GBM brain tumors. The SEER program provides extensive cancer statistics, covering nearly 48% of the U.S. population.
Key Findings on Incidence Trends
The study revealed that GBM incidence rates have been steadily increasing over the study period, with an annual rise of 0.022 cases per 100,000 people. In contrast, the rates of non-GBM brain tumors have shown a significant decline, decreasing by 0.033 cases per 100,000 annually. These findings highlight a shift in brain tumor diagnoses, suggesting improved accuracy in identifying GBM.
Across different regions of the United States, the increase in GBM cases was evident. The Northeast experienced the highest annual growth rate at 0.037 cases per 100,000, followed by the Midwest, South, and West. Conversely, non-GBM rates declined across all regions, with the most substantial decreases observed in the Northeast and South. This data underscores regional variations in diagnostic practices and healthcare accessibility.
Regional and State-Specific Insights
The research also delved into state-specific data, showing significant disparities in GBM incidence rates. States such as Massachusetts, New Jersey, and New York reported higher rates compared to others like Alaska, Hawaii, and New Mexico. These differences may reflect variations in healthcare infrastructure, diagnostic capabilities, and population demographics.
The study’s findings align with global trends, as countries such as Finland, England, and Australia have also reported rising GBM rates. Improved diagnostic technologies, including the use of molecular markers like IDH1 mutations and EGFR amplifications, have played a pivotal role in differentiating GBM from other brain tumors.
What Is Driving the Increase in GBM Cases?
The observed increase in GBM cases can be attributed to advancements in medical technology and diagnostic practices. The introduction of molecular markers and updates to the World Health Organization’s cl
assification of central nervous system tumors have significantly enhanced the precision of GBM diagnosis. These improvements allow for more accurate differentiation between GBM and other tumor types, leading to better tracking of disease trends.
However, the study also raises questions about whether the rise in GBM cases represents a true increase in prevalence or is primarily driven by enhanced diagnostic accuracy. The decline in non-GBM tumor rates suggests that some cases previously classified as non-GBM are now being correctly identified as GBM.
Thailand
Medical News would like to add that studies and new data are also indicting that COVID-19 and the mRNA vaccines could also be contributing to the rise of incidences of glioblastoma.
https://www.thailandmedical.news/news/breaking-texas-md-anderson-study-finds-that-covid-19-accelerates-brain-tumor-progression-and-possibly-causes-new-onset-glioblastomas
https://www.thailandmedical.news/news/breaking-covid-19-news-study-finds-that-covid-19-hospitalization-linked-to-elevated-glioblastoma-risk-a-type-of-aggressive-brain-cancer
https://www.thailandmedical.news/news/sars-cov-2-and-cancer-increased-neuropilin-1-expression-as-a-result-of-covid-19-can-lead-to-progression-of-primary-brain-tumors-besides-neurological-i
Challenges and Implications for Public Health
While the increase in GBM diagnoses reflects progress in medical science, it also highlights ongoing challenges in ensuring equitable healthcare access. Rural areas and regions with limited medical resources may lag in adopting advanced diagnostic technologies, potentially leading to underdiagnosis or misclassification of brain tumors.
Targeted efforts are needed to address these disparities and ensure that advancements in medical technology benefit all communities. This includes investing in healthcare infrastructure, providing specialized training for healthcare professionals, and expanding access to diagnostic tools in underserved areas.
Conclusion
The rising incidence of Glioblastoma Multiforme in the United States underscores the importance of continued advancements in medical diagnostics and cancer research. While the increase in GBM cases is partly attributable to improved diagnostic precision, it also highlights the need for ongoing efforts to understand the underlying causes of this deadly disease. Regional disparities in GBM rates call for targeted public health interventions to ensure that all populations have access to accurate and timely diagnoses.
As the medical community works to address these challenges, the findings of this study provide valuable insights for shaping future research and healthcare policies. Efforts to enhance diagnostic accuracy, expand access to healthcare resources, and understand the epidemiology of GBM are essential for improving outcomes for patients affected by this devastating condition.
The study findings were published on a preprint server and are currently being peer reviewed.
https://www.researchsquare.com/article/rs-5423792/v1
For the latest Glioblastoma News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/understanding-glioblastoma-recurrence-and-survival
https://www.thailandmedical.news/news/exploring-natural-compounds-derived-from-peruvian-maca-lepidium-meyenii-to-tackle-glioblastoma-multiforme
Share
Tweet
Share
